Latanoprost Kent Pharma Uk

Latanoprost, the active ingredient in Latanoprost Kent Pharma Uk, is a Prostaglandin F2α analog presented as an ophthalmic solution for ocular use. It treats primary open‑angle glaucoma and ocular hypertension in adults. GNH USA supplies Latanoprost Kent Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma and related conditions.

Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma. Secondary open‑angle glaucoma: helps control pressure when other causes are present.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness or hyperemia - Increased eyelash length and density - Darkening of the iris pigment - Eye irritation or foreign‑body sensation - Blurred vision - Mild eye pain

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema) - Uveitis or intra‑ocular inflammation - Corneal edema or keratitis - Paradoxical increase in intra‑ocular pressure - Macular edema - Vision loss

Before prescribing Latanoprost, clinicians should consider several safety aspects.

Monitor intra‑ocular pressure regularly: ensure therapeutic effect and detect hypotony. Assess for ocular infections: avoid use in active conjunctivitis or keratitis. Caution in patients with herpes simplex keratitis: may exacerbate infection. Pregnancy and breastfeeding: use only if benefits outweigh risks. Avoid contact lens wear for the first week: potential irritation. Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analogues: risk of excessive IOP reduction. - Combination with ocular corticosteroids: increased risk of cataract formation. - Use with beta‑blocker eye drops: may cause overly low IOP.

Moderate Interactions (Monitor Closely): - Co‑administration with antihistamine eye drops: may increase ocular irritation. - Use with preservative‑containing contact lens solutions: potential for increased discomfort.